Over 100 healthcare provider groups oppose HHS's proposed HIPAA cybersecurity update amid financial and timing concerns. Sector faces changes in Medicare Advantage, 340B, and insurance market consolidation.
CMS’s 2026 OPPS final rule updates outpatient payment policies, adjusts 340B drug recoupment, extends site-neutral payment models, expands ASC services, and enhances hospital price transparency requirements effective January 2026.
CMS unveils the GENERous Medicaid payment model introducing MFN drug pricing, alongside expanded Trump administration drug pricing agreements and key regulatory updates for 2026.
FDA approves prescription leucovorin for autism treatment; HHS addresses investment and regulatory concerns involving CMS administrator Dr. Mehmet Oz amid public discourse.
Recent U.S. healthcare updates cover a $34.8M Medicare fraud case, HHS action on organ recovery agency safety, youth fitness legislation, and ACIP's hepatitis B vaccine deliberations.
CMS launches AI-driven pilot to streamline Medicare prior authorization for select services, prompting legislative calls for independent oversight to ensure patient safety and regulatory compliance.
Medicare initiates an AI-based pilot program to aid in approving or denying certain medical procedures, raising considerations about healthcare administrative processes and payer-provider dynamics.
A federal judge blocks major Trump-era ACA provisions that could lead to 1.8 million losing coverage, citing regulatory overreach and increased health costs.
UnitedHealth Group responds to DOJ investigations into Medicare Advantage amid broader insurance market changes including AI automation and pharmaceutical supply dynamics.
CMS's 2026 proposed rules for Medicare Part B include major updates to average sales price calculations, Inflation Reduction Act compliance, ASP documentation, and Medicare inflation rebates affecting government pricing.
